Digital twins in life science
Mantis Biotech is developing synthetic representations of human biology to address data gaps and enable faster, safer discovery pipelines. By integrating disparate data sources into a digital twin framework, the company aims to democratize access to high-quality datasets for researchers and clinicians, catalyzing breakthroughs in drug development and personalized medicine.
Key challenges include data standardization, provenance, and regulatory compliance for synthetic data. The company’s strategy hinges on robust privacy-preserving techniques and transparent documentation of data lineage. If successful, this approach could reduce the time and cost of clinical research while enabling more rigorous testing and scenario analysis across diverse patient populations.
As digital twins mature, they will necessitate new governance models to ensure reproducibility, data ethics, and responsible use in clinical settings. The health AI ecosystem will benefit from cross-disciplinary collaboration between bioinformatics, AI safety, and clinical governance to translate digital twin capabilities into tangible patient outcomes.